» Articles » PMID: 16299327

Pseudomonas Aeruginosa Acquires Biofilm-like Properties Within Airway Epithelial Cells

Overview
Journal Infect Immun
Date 2005 Nov 22
PMID 16299327
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Pseudomonas aeruginosa can notably cause both acute and chronic infection. While several virulence factors are implicated in the acute phase of infection, advances in understanding bacterial pathogenesis suggest that chronic P. aeruginosa infection is related to biofilm formation. However, the relationship between these two forms of disease is not well understood. Accumulating evidence indicates that, during acute infection, P. aeruginosa enters epithelial cells, a process viewed as either a host-mediated defense response or a pathogenic mechanism to avoid host-mediated killing. We investigated the possibility that epithelial cell entry during early P. aeruginosa-epithelial cell contact favors bacterial survival and is linked to chronic infection. Using electron microscopy and confocal microscopy to analyze primary culture airway epithelial cells infected with P. aeruginosa, we found that epithelial cells developed pod-like clusters of intracellular bacteria with regional variation in protein expression. Extracellular gentamicin added to the medium after acute infection led to the persistence of intracellular P. aeruginosa for at least 3 days. Importantly, compared to bacterial culture under planktonic conditions, the intracellular bacteria were insensitive to growth inhibition or killing by antibiotics that were capable of intraepithelial cell penetration. These findings suggest that P. aeruginosa can use airway epithelial cells as a sanctuary for persistence and develop a reversible antibiotic resistance phenotype characteristic of biofilm physiology that can contribute to development of chronic infection.

Citing Articles

Intracellular Pseudomonas aeruginosa persist and evade antibiotic treatment in a wound infection model.

Pont S, Nilly F, Berry L, Bonhoure A, Alford M, Louis M PLoS Pathog. 2025; 21(2):e1012922.

PMID: 39946497 PMC: 11825101. DOI: 10.1371/journal.ppat.1012922.


Effectiveness of a Novel Liposomal Methylglyoxal-Tobramycin Formulation in Reducing Biofilm Formation and Bacterial Adhesion.

Alluhaim W, Alkhulaifi M, Alzahrani R, Alrfaei B, Yassin A, Alghoribi M Antibiotics (Basel). 2025; 14(1).

PMID: 39858289 PMC: 11763214. DOI: 10.3390/antibiotics14010003.


Evidence for intracellular .

Resko Z, Suhi R, Thota A, Kroken A J Bacteriol. 2024; 206(5):e0010924.

PMID: 38597609 PMC: 11112991. DOI: 10.1128/jb.00109-24.


Intracellular : An Overlooked Reservoir in the Lungs of People with Cystic Fibrosis?.

Crabbe A Am J Respir Crit Care Med. 2024; 209(12):1421-1423.

PMID: 38498854 PMC: 11208970. DOI: 10.1164/rccm.202402-0388ED.


Pseudomonas aeruginosa Induces Interferon-β Production to Promote Intracellular Survival.

Yang L, Zhang Y, Liu Y, Xie Y, Weng D, Ge B Microbiol Spectr. 2022; 10(5):e0155022.

PMID: 36190409 PMC: 9603546. DOI: 10.1128/spectrum.01550-22.


References
1.
Cazzola M, Matera M, Polverino M, Santangelo G, De Franchis I, Rossi F . Pulmonary penetration of ceftazidime. J Chemother. 1995; 7(1):50-4. DOI: 10.1179/joc.1995.7.1.50. View

2.
Elsinghorst E . Measurement of invasion by gentamicin resistance. Methods Enzymol. 1994; 236:405-20. DOI: 10.1016/0076-6879(94)36030-8. View

3.
Fleiszig S, Zaidi T, Preston M, Grout M, Evans D, Pier G . Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun. 1996; 64(6):2288-94. PMC: 174068. DOI: 10.1128/iai.64.6.2288-2294.1996. View

4.
Cavet M, West M, Simmons N . Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells. Antimicrob Agents Chemother. 1998; 41(12):2693-8. PMC: 164190. DOI: 10.1128/AAC.41.12.2693. View

5.
Feldman M, Bryan R, Rajan S, Scheffler L, Brunnert S, Tang H . Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection. Infect Immun. 1998; 66(1):43-51. PMC: 107856. DOI: 10.1128/IAI.66.1.43-51.1998. View